| 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ... Polish Heart Journal (Kardiologia Polska) 73 (12), 1207-1294, 2015 | 8340 | 2015 |
| Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study SR Mehta, S Yusuf, RJG Peters, ME Bertrand, BS Lewis, MK Natarajan, ... The Lancet 358 (9281), 527-533, 2001 | 4586 | 2001 |
| Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. S Yusuf, SR Mehta, S Chrolavicius, J Pogue, CB Granger, A Budaj, ... JAMA: Journal of the American Medical Association 295 (13), 2006 | 1220 | 2006 |
| Cholesterol lowering in intermediate-risk persons without cardiovascular disease S Yusuf, J Bosch, G Dagenais, J Zhu, D Xavier, L Liu, P Pais, ... New England Journal of Medicine 374 (21), 2021-2031, 2016 | 1086 | 2016 |
| Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to … RJG Peters, SR Mehta, KAA Fox, F Zhao, BS Lewis, SL Kopecky, R Diaz, ... Circulation 108 (14), 1682-1687, 2003 | 1018 | 2003 |
| Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non–ST-elevation acute coronary syndrome: the Clopidogrel … KAA Fox, SR Mehta, R Peters, F Zhao, N Lakkis, BJ Gersh, S Yusuf Circulation 110 (10), 1202-1208, 2004 | 1012 | 2004 |
| Blood-pressure lowering in intermediate-risk persons without cardiovascular disease EM Lonn, J Bosch, P López-Jaramillo, J Zhu, L Liu, P Pais, R Diaz, ... New England Journal of Medicine 374 (21), 2009-2020, 2016 | 840 | 2016 |
| Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography M Deschasaux, KE Bouter, A Prodan, E Levin, AK Groen, H Herrema, ... Nature medicine 24 (10), 1526-1531, 2018 | 575 | 2018 |
| Blood-pressure and cholesterol lowering in persons without cardiovascular disease S Yusuf, E Lonn, P Pais, J Bosch, P Lopez-Jaramillo, J Zhu, D Xavier, ... New England Journal of Medicine 374 (21), 2032-2043, 2016 | 510 | 2016 |
| Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers NR Bijsterveld, AH Moons, SM Boekholdt, BE van Aken, H Fennema, ... Circulation 106 (20), 2550-2554, 2002 | 393 | 2002 |
| Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries G De Backer, P Jankowski, K Kotseva, E Mirrakhimov, Ž Reiner, L Ryden, ... Atherosclerosis 285, 135-146, 2019 | 382 | 2019 |
| Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial SR Mehta, CB Granger, JW Eikelboom, JP Bassand, L Wallentin, ... Journal of the American College of Cardiology 50 (18), 1742-1751, 2007 | 353 | 2007 |
| Clinical application and image interpretation in intracoronary ultrasound C Di Mario, G Görge, R Peters, P Kearney, F Pinto, D Hausmann, ... European heart journal 19 (2), 207-229, 1998 | 320 | 1998 |
| Tissue factor and coronary artery disease AHM Moons, M Levi, RJG Peters Cardiovascular Research 53 (2), 313-325, 2002 | 300 | 2002 |
| Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review SM Boekholdt, NR Bijsterveld, AHM Moons, M Levi, HR Büller, ... Circulation 104 (25), 3063-3068, 2001 | 296 | 2001 |
| Unravelling the impact of ethnicity on health in Europe: the HELIUS study K Stronks, MB Snijder, RJG Peters, M Prins, AH Schene, AH Zwinderman BMC public health 13, 1-10, 2013 | 291 | 2013 |
| Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events SM Boekholdt, WRP Agema, RJG Peters, AH Zwinderman, ... Circulation 107 (19), 2416-2421, 2003 | 291 | 2003 |
| Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European … SM Boekholdt, JA Kuivenhoven, NJ Wareham, RJG Peters, JW Jukema, ... Circulation 110 (11), 1418-1423, 2004 | 273 | 2004 |
| Distribution of estimated 10-year risk of recurrent vascular events and residual risk in a secondary prevention population L Kaasenbrood, SM Boekholdt, Y Van Der Graaf, KK Ray, RJG Peters, ... Circulation 134 (19), 1419-1429, 2016 | 271 | 2016 |
| Smoking and the patency of lower extremity bypass grafts: a meta-analysis EM Willigendael, JAW Teijink, ML Bartelink, RJG Peters, HR Büller, ... Journal of vascular surgery 42 (1), 67-74, 2005 | 268 | 2005 |
